Susanna Naggie, MD

Publications

Younossi, ZM, Stepanova, M, Sulkowski, M, Naggie, S, Puoti, M, Orkin, C, and Hunt, SL. "Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes." The Journal of infectious diseases 212, no. 3 (August 2015): 367-377.

PMID
25583164
Full Text

Naggie, S, Cooper, C, Saag, M, Workowski, K, Ruane, P, Towner, WJ, Marks, K, Luetkemeyer, A, Baden, RP, Sax, PE, Gane, E, Santana-Bagur, J, Stamm, LM, Yang, JC, German, P, Dvory-Sobol, H, Ni, L, Pang, PS, McHutchison, JG, Stedman, CAM, Morales-Ramirez, JO, Bräu, N, Jayaweera, D, Colson, AE, Tebas, P, Wong, DK, Dieterich, D, Sulkowski, M, and ION-4 Investigators, . "Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1." The New England journal of medicine 373, no. 8 (August 2015): 705-713.

PMID
26196665
Full Text

Naggie, S, Cooper, C, Saag, M, Yang, JC, Stamm, LM, Pang, PS, McHutchison, JG, Dieterich, D, and Sulkowski, MS. "Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1." JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 18 (July 2015).

Full Text

Horner, SM, and Naggie, S. "Successes and Challenges on the Road to Cure Hepatitis C." PLoS pathogens 11, no. 6 (June 18, 2015): e1004854-. (Review)

PMID
26087286
Full Text

Matthews, GV, Neuhaus, J, Bhagani, S, Mehta, SH, Vlahakis, E, Doroana, M, Naggie, S, Arenas-Pinto, A, Peters, L, Rockstroh, JK, and International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group, . "Baseline prevalence and predictors of liver fibrosis among HIV-positive individuals: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial." HIV medicine 16 Suppl 1 (April 2015): 129-136.

PMID
25711331
Full Text

Naggie, S, Patel, K, Yang, L-Y, Chow, S-C, Johnson, V, Guyton, JR, Muir, AJ, Sulkowski, M, and Hicks, C. "Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals." Open forum infectious diseases 2, no. 2 (April 2015): ofv066-.

PMID
26110167
Full Text

Naggie, S, Alam, I, Manch, RA, Reindollar, R, Slim, J, Prabhakar, A, Lauwers, K, Donovan, C, Tandon, N, Forlenza, JB, and Brown, K. "Effectiveness of Simeprevir (SMV) - Containing Regimens Among Patients With Chronic Hepatitis C Virus (HCV) in Various US Practice Settings: Interim Analysis of the Sonet Study." April 2015.

Scholars@Duke

Swiderska-Syn, M, Choi, S, Lan, A, Ferrari, G, Diehl, AM, and Naggie, S. "P0469 : Markers of tissue repair and cellular aging are increased in liver tissue of patients with dual chronic HIV/HCV infections." April 2015.

Full Text

Cooper, C, Naggie, S, Saag, M, Yang, J, Stamm, L, Pang, P, McHutchison, J, Dieterich, D, and Sulkowski, M. "A SINGLE TABLET REGIMEN OF LEDIPASVIR/SOFOSBUVIR FOR 12 WEEKS IN HCV GENOTYPE 1 OR 4 INFECTED PATIENTS WITH HIV-1 CO-INFECTION: THE PHASE 3 ION-4 STUDY." April 2015.

Scholars@Duke

Alam, I, Manch, R, Naggie, S, Reindollar, R, Slim, J, Prabhakar, A, Lauwers, K, Donovan, C, Tandon, N, Forlenza, J, and Brown, K. "EFFECTIVENESS OF SIMEPREVIR (SMV)-CONTAINING REGIMENS AMONG PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) IN VARIOUS US PRACTICE SETTINGS: INTERIM ANALYSIS OF THE SONET STUDY." April 2015.

Scholars@Duke

Pages